Drugs / Melagatran
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00206089 | Sep 2005 → Aug 2006 | venous thromboembolism | AstraZeneca | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Melagatran | “melagatran injection followed by ximelagatran tablets” NCT00206089 ↗ |
| Modality | Small molecule | — CHEMBL266349 ↗ |